Mr. Carter Brownlee reports

HIGH TIDE REPORTS RECORD QUARTERLY DISTRIBUTION OF 7.6 TONNES OF MEDICAL CANNABIS THROUGH REMEXIAN PHARMA GMBH, ACCELERATING GERMAN MARKET LEADERSHIP

High Tide Inc. has released preliminary tonnage data from its 51-per-cent-owned German subsidiary, Remexian Pharma GmbH, for the second fiscal quarter ended April 30, 2026.

During the quarter, Remexian sold 7.6 tonnes of medical cannabis into the German market, representing the highest quarterly distribution volume in its history. Volumes increased 21 per cent on a sequential basis and 49 per cent year over year.

"Distributing 7.6 tonnes in a single quarter is not just a record for Remexian -- it is clear evidence that our model is scaling in the largest medical cannabis market in Europe. What we are seeing now is the direct result of pairing a leading German distribution platform with High Tide's unparalleled procurement capabilities built over $2.2-billion of legal cannabis sales in Canada," said Raj Grover, founder and chief executive officer of High Tide.

"This level of sequential and year-over-year growth reinforces our conviction that Germany is only the beginning. We are building a repeatable, capital-efficient distribution engine that can be expanded across Europe, subject to regulatory conditions. We fully intend to leverage this momentum to continue taking share in Germany while methodically entering additional high-growth markets," added Mr. Grover.

Germany imported 201.1 tonnes of medical cannabis in 2025, more than doubling the previous year's 72.9 tonnes, with almost half of its imports (over 93 tonnes) coming from Canada.

The foregoing Remexian tonnage figures are preliminary, unaudited and subject to revision upon completion of the company's second fiscal quarter financial statements. They have not been reviewed or approved by the company's audit committee or board of directors, and should not be relied upon as a substitute for the complete financial results that the company expects to report in June, 2026. Accordingly, these figures may differ from the amounts ultimately reported in the company's interim financial statements and management's discussion and analysis for the quarter ended April 30, 2026. The company will report its complete second fiscal quarter 2026 financial results, including revenue, gross profit, net income (loss) and adjusted EBITDA (earnings before interest, taxes, depreciation and amortization), in June, 2026.

About High Tide Inc.

High Tide is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide is uniquely built around the cannabis consumer, with wholly diversified and fully integrated operations across all components of cannabis, including:

Retail: Canna Cabana is the largest cannabis retail chain in Canada, with 221 domestic and one international location. The company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba and Ontario, holding a growing 12-per-cent share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.

Medical cannabis distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices, with a market share exceeding 10 per cent of tonnage imported. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.

High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange in 2022, 2024 and 2025. High Tide was also ranked No. 1 in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023.

We seek Safe Harbor.